Prognostic histopathological and molecular markers in feline mammary neoplasia

Veterinary Journal

Volumn 194, Issue 1, 2012, Pages 19-26

  Hughes, K ^a   Dobson, J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Feline; Immunohistochemistry; Mammary tumour; Pathology; Prognosis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYCLINE; CYCLOOXYGENASE 2; DNA TOPOISOMERASE (ATP HYDROLYSING); EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; MOLECULAR MARKER; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN KINASE B; PROTEIN P53; STAT3 PROTEIN; STEROID RECEPTOR; TELOMERASE; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CAT; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME SYNTHESIS; EXPERIMENTAL NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; MITOSIS INDEX; NONHUMAN; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR VOLUME;

ANIMALS; CAT DISEASES; CATS; FEMALE; MAMMARY NEOPLASMS, ANIMAL; TUMOR MARKERS, BIOLOGICAL;

FELIDAE;

EID: 84868209521     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2012.05.008     Document Type: Review

References (96)

1. Amorim F.V., Souza H.J., Ferreira A.M., Fonseca A.B. Clinical, cytological and histopathological evaluation of mammary masses in cats from Rio de Janeiro, Brazil. Journal of Feline Medicine and Surgery 2006, 8:379-388.
2. Barber D.F., Alvarado-Kristensson M., Gonzalez-Garcia A., Pulido R., Carrera A.C. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase. Science's STKE: Signal Transduction Knowledge, Environment 2006, pe49.
3. Beam S.L., Rassnick K.M., Moore A.S., McDonough S.P. An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Veterinary Pathology 2003, 40:496-500.
4. *. Veterinary and Comparative Oncology 2009, 7:213-221.
5. Bukholm I.R., Bukholm G., Nesland J.M. Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. International Journal of Cancer 2001, 93:283-287.
6. Burger J.A., Kipps T.J. CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
7. Burrai G.P., Mohammed S.I., Miller M.A., Marras V., Pirino S., Addis M.F., Uzzau S., Antuofermo E. Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions. BMC Cancer 2010, 10:156.
8. Camp E.R., Liu W., Fan F., Yang A., Somcio R., Ellis L.M. RON, a tyrosine kinase receptor involved in tumor progression and metastasis. Annals of Surgical Oncology 2005, 12:273-281.
9. Capodanno A., Camerini A., Orlandini C., Baldini E., Resta M.L., Bevilacqua G., Collecchi P. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma. Human Pathology 2009, 40:1408-1417.
10. Cardazzo B., Zappulli V., Frassineti F., Patarnello T., Castagnaro M., Bargelloni L. Full-length sequence and expression analysis of estrogen receptor alpha mRNA in feline mammary tumors. The Journal of Steroid Biochemistry and Molecular Biology 2005, 96:109-118.
11. Castagnaro M., Casalone C., Bozzetta E., De Maria R., Biolatti B., Caramelli M. Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas. Journal of Comparative Pathology 1998, 119:263-275.
12. Castagnaro M., De Maria R., Bozzetta E., Ru G., Casalone C., Biolatti B., Caramelli M. Ki-67 index as indicator of the post-surgical prognosis in feline mammary carcinomas. Research in Veterinary Science 1998, 65:223-226.
13. de las Mulas J.M., van Niel M., Millan Y., Blankenstein M.A., van Mil F., Misdorp W. Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay. Domestic Animal Endocrinology 2000, 18:111-125.
14. De Maria R., Maggiora P., Biolatti B., Prat M., Comoglio P.M., Castagnaro M., Di Renzo M.F. Feline STK gene expression in mammary carcinomas. Oncogene 2002, 21:1785-1790.
15. De Maria R., Olivero M., Iussich S., Nakaichi M., Murata T., Biolatti B., Di Renzo M.F. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Research 2005, 65:907-912.
16. De Vico G., Maiolino P. Prognostic value of nuclear morphometry in feline mammary carcinomas. Journal of Comparative Pathology 1997, 117:99-105.
17. De Vico G., Maiolino P., Restucci B. Silver-stained nucleolar (Ag-NOR) cluster size in feline mammary carcinomas: Lack of correlation with histological appearance, mitotic activity, tumour stage, and degree of nuclear atypia. Journal of Comparative Pathology 1995, 113:69-73.
18. Delli Carpini J., Karam A.K., Montgomery L. Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer. Angiogenesis 2010, 13:43-58.
19. Derenzini M. The AgNORs. Micron 2000, 31:117-120.
20. Dias Pereira P., Carvalheira J., Gartner F. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue - An immunohistochemical study. The Veterinary Journal 2004, 168:180-185.
21. Dillon R.L., White D.E., Muller W.J. The phosphatidyl inositol 3-kinase signaling network: Implications for human breast cancer. Oncogene 2007, 26:1338-1345.
22. Dincer Z., Jasani B., Haywood S., Mullins J.E., Fuentealba I.C. Metallothionein expression in canine and feline mammary and melanotic tumours. Journal of Comparative Pathology 2001, 125:130-136.
23. Dorn C.R., Taylor D.O., Frye F.L., Hibbard H.H. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. I. Methodology and description of cases. Journal of the National Cancer Institute 1968, 40:295-305.
24. Dorn C.R., Taylor D.O., Schneider R., Hibbard H.H., Klauber M.R. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. Journal of the National Cancer Institute 1968, 40:307-318.
25. Elston C.W., Ellis I.O., Symmers W.S.C. Assessment of histological grade. Breast 1998, vol.13:356-384. Churchill Livingstone, Edinburgh.
26. Fusaro L., Panarese S., Brunetti B., Zambelli D., Benazzi C., Sarli G. Quantitative analysis of telomerase in feline mammary tissues. Journal of Veterinary Diagnostic Investigation: Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2009, 21:369-373.
27. Gimenez F., Hecht S., Craig L.E., Legendre A.M. Early detection, aggressive therapy: optimizing the management of feline mammary masses. Journal of Feline Medicine and Surgery 2010, 12:214-224.
28. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
29. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
30. Harris C.C. P53 tumor suppressor gene: from the basic research laboratory to the clinic - An abridged historical perspective. Carcinogenesis 1996, 17:1187-1198.
31. Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield M.R., Hayes D.F., Bast R.C. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2007, 25:5287-5312.
32. Hayden D.W., Nielsen S.W. Feline mammary tumours. Journal of Small Animal Practice 1971, 12:687-698.
33. Hayes A., Scase T., Miller J., Murphy S., Sparkes A., Adams V. COX-1 and COX-2 expression in feline oral squamous cell carcinoma. Journal of Comparative Pathology 2006, 135:93-99.
34. Hayes A.A., Mooney S. Feline mammary tumors. The veterinary clinics of North America. Small Animal Practice 1985, 15:513-520.
35. Hayes H.M., Milne K.L., Mandell C.P. Epidemiological features of feline mammary carcinoma. Veterinary Record 1981, 108:476-479.
36. Ivanyi D., Minke J.M., Hageman C., Groeneveld E., van Doornewaard G., Misdorp W. Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas. American Journal of Veterinary Research 1993, 54:1095-1102.
37. Jacobs T.M., Hoppe B.R., Poehlmann C.E., Ferracone J.D., Sorenmo K.U. Mammary adenocarcinomas in three male cats exposed to medroxyprogesterone acetate (1990-2006). Journal of Feline Medicine and Surgery 2010, 12:169-174.
38. Keskin A., Yilmazbas G., Yilmaz R., Ozyigit M.O., Gumen A. Pathological abnormalities after long-term administration of medroxyprogesterone acetate in a queen. Journal of Feline Medicine and Surgery 2009, 11:518-521.
39. Kusewitt D., Rush L. Neoplasia and tumor biology. Pathologic Basis of Veterinary Disease 2007, 260-265. Mosby Elsevier, St. Louis, Mo, USA. M.D. McGavin, J.F. Zachary (Eds.).
40. Levine A.J. P53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
41. Long S., Argyle D.J., Nixon C., Nicholson I., Botteron C., Olby N., Platt S., Smith K., Rutteman G.R., Grinwis G.C., Nasir L. Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumours. Neuropathology and Applied Neurobiology 2006, 32:662-673.
42. Lucci A., Krishnamurthy S., Singh B., Bedrosian I., Meric-Bernstam F., Reuben J., Broglio K., Mosalpuria K., Lodhi A., Vincent L., Cristofanilli M. Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Breast Cancer Research and Treatment 2009, 117:61-68.
43. Maggiora P., Marchio S., Stella M.C., Giai M., Belfiore A., De Bortoli M., Di Renzo M.F., Costantino A., Sismondi P., Comoglio P.M. Overexpression of the RON gene in human breast carcinoma. Oncogene 1998, 16:2927-2933.
44. Makiniemi M., Hillukkala T., Tuusa J., Reini K., Vaara M., Huang D., Pospiech H., Majuri I., Westerling T., Makela T.P., Syvaoja J.E. BRCT domain-containing protein TopBP1 functions in DNA replication and damage response. The Journal of Biological Chemistry 2001, 276:30399-30406.
45. Maniscalco L., Iussich S., de Las Mulas J.M., Millan Y., Biolatti B., Sasaki N., Nakagawa T., De Maria R. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours. Veterinary Journal 2012, 191:65-71.
46. Malumbres M., Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nature Reviews. Cancer 2001, 1:222-231.
47. Martin de las Mulas J., Espinosa de los Monteros A., Bautista M.J., Gomez-Villamandos J.C., Morales C. Immunohistochemical distribution pattern of intermediate filament proteins and muscle actin in feline and human mammary carcinomas. Journal of Comparative Pathology 1994, 111:365-381.
48. Martin de las Mulas J., Van Niel M., Millan Y., Ordas J., Blankenstein M.A., Van Mil F., Misdorp W. Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status. Research in Veterinary Science 2002, 72:153-161.
49. McAloose D., Munson L., Naydan D.K. Histologic features of mammary carcinomas in zoo felids treated with melengestrol acetate (MGA) contraceptives. Veterinary Pathology 2007, 44:320-326.
50. Millanta F., Calandrella M., Bari G., Niccolini M., Vannozzi I., Poli A. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Research in Veterinary Science 2005, 79:225-232.
51. Millanta F., Calandrella M., Citi S., Della Santa D., Poli A. Overexpression of HER-2 in feline invasive mammary carcinomas: An immunohistochemical survey and evaluation of its prognostic potential. Veterinary Pathology 2005, 42:30-34.
52. Millanta F., Citi S., Della Santa D., Porciani M., Poli A. COX-2 expression in canine and feline invasive mammary carcinomas: Correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Research and Treatment 2006, 98:115-120.
53. Millanta F., Lazzeri G., Vannozzi I., Viacava P., Poli A. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas. Veterinary Pathology 2002, 39:690-696.
54. Millanta F., Silvestri G., Vaselli C., Citi S., Pisani G., Lorenzi D., Poli A. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: A preliminary study of autocrine and paracrine loops. Research in Veterinary Science 2006, 81:350-357.
55. Misdorp, W., Else, R., Hellmen, E., Lipscomb, T., 1999. Feline. In: Histological Classification of Mammary Tumors of the Dog and the Cat. Armed Forces Institute of Pathology in cooperation with the American Registry of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, Washington, pp. 23-29.
56. Morris J.S., Nixon C., Bruck A., Nasir L., Morgan I.M., Philbey A.W. Immunohistochemical expression of TopBP1 in feline mammary neoplasia in relation to histological grade, Ki67, ERalpha and p53. The Veterinary Journal 2008, 175:218-226.
57. Munson L., Moresco A. Comparative pathology of mammary gland cancers in domestic and wild animals. Breast Disease 2007, 28:7-21.
58. Murakami Y., Tateyama S., Rungsipipat A., Uchida K., Yamaguchi R. Amplification of the cyclin A gene in canine and feline mammary tumors. The Journal of Veterinary Medical Science/The Japanese Society of Veterinary Science 2000, 62:783-787.
59. Murakami Y., Tateyama S., Rungsipipat A., Uchida K., Yamaguchi R. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats. The Journal of Veterinary Medical Science/The Japanese Society of Veterinary Science 2000, 62:743-750.
60. Nakano M., Wu H., Taura Y., Inoue M. Immunohistochemical detection of Mdm2 and p53 in feline mammary gland tumors. The Journal of Veterinary Medical Science/The Japanese Society of Veterinary Science 2006, 68:421-425.
61. Nasir L., Krasner H., Argyle D.J., Williams A. Immunocytochemical analysis of the tumour suppressor protein (p53) in feline neoplasia. Cancer Letters 2000, 155:1-7.
62. Oonuma T., Morimatsu M., Nakagawa T., Uyama R., Sasaki N., Nakaichi M., Tamamura H., Fujii N., Hashimoto S., Yamamura H., Syuto B. Role of CXCR4 and SDF-1 in mammary tumor metastasis in the cat. The Journal of Veterinary Medical Science/The Japanese Society of Veterinary Science 2003, 65:1069-1073.
63. Ordas J., Millan Y., Dios R., Reymundo C., de Las Mulas J.M. Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: An immunohistochemical and chromogenic in situ hybridization study. BMC Cancer 2007, 7:179.
64. Overley B., Shofer F.S., Goldschmidt M.H., Sherer D., Sorenmo K.U. Association between ovarihysterectomy and feline mammary carcinoma. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 2005, 19:560-563.
65. Pang L.Y., Argyle D. Cancer stem cells and telomerase as potential biomarkers in veterinary oncology. The Veterinary Journal 2010, 185:15-22.
66. Penafiel-Verdu C., Buendia A.J., Navarro J.A., Ramirez G.A., Vilafranca M., Altimira J., Sanchez J. Reduced expression of E-cadherin and beta-catenin and high expression of basal cytokeratins in feline mammary carcinomas with regional metastasis. Veterinary Pathology 2012, 10.1177/0300985812436744.
67. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A., Fluge O., Pergamenschikov A., Williams C., Zhu S.X., Lonning P.E., Borresen-Dale A.L., Brown P.O., Botstein D. Molecular portraits of human breast tumours. Nature 2000, 406:747-752.
68. Petterino C., Podesta G., Ratto A., Drigo M., Pellegrino C. Immunohistochemical study of phospho-Stat3-ser727 expression in feline mammary gland tumours. Veterinary Research Communications 2007, 31:173-184.
69. Petterino C., Ratto A., Podesta G., Drigo M., Pellegrino C. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade. Research in Veterinary Science 2007, 82:218-224.
70. Pharoah P.D., Day N.E., Caldas C. Somatic mutations in the p53 gene and prognosis in breast cancer: A meta-analysis. British Journal of Cancer 1999, 80:1968-1973.
71. Pich A., Chiusa L., Margaria E. Prognostic relevance of AgNORs in tumor pathology. Micron 2000, 31:133-141.
72. Preziosi R., Sarli G., Benazzi C., Mandrioli L., Marcato P.S. Multiparametric survival analysis of histological stage and proliferative activity in feline mammary carcinomas. Research in Veterinary Science 2002, 73:53-60.
73. Preziosi R., Sarli G., Benazzi C., Marcato P.S. Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours. Journal of Comparative Pathology 1995, 113:301-313.
74. Rasotto R., Caliari D., Castagnaro M., Zanetti R., Zappulli V. An immunohistochemical study of HER-2 expression in feline mammary tumours. Journal of Comparative Pathology 2011, 144:170-179.
75. Reis-Filho J.S., Pusztai L. Gene expression profiling in breast cancer: Classification, prognostication, and prediction. Lancet 2011, 378:1812-1823.
76. Renwick M.G., Argyle D.J., Long S., Nixon C., Gault E.A., Nasir L. Telomerase activity and telomerase reverse transcriptase catalytic subunit expression in canine lymphoma: Correlation with Ki67 immunoreactivity. Veterinary and Comparative Oncology 2006, 4:141-150.
77. Ressel L., Millanta F., Caleri E., Innocenti V.M., Poli A. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors. Veterinary Pathology 2009, 46:860-868.
78. Rutteman G.R., Misdorp W. Hormonal background of canine and feline mammary tumours. Journal of Reproduction and Fertility Suppl. 1993, 47:483-487.
79. Salisbury J.R. Molecular histopathology. Molecular Pathology 1997, 107-115. Taylor and Francis, London, UK.
80. Sayasith K., Sirois J., Dore M. Molecular characterization of feline COX-2 and expression in feline mammary carcinomas. Veterinary Pathology 2009, 46:423-429.
81. Schmitt F. HER2+ breast cancer: how to evaluate?. Advances in Therapy 2009, 26:S1-S8.
82. Seixas F., Palmeira C., Pires M.A., Bento M.J., Lopes C. Grade is an independent prognostic factor for feline mammary carcinomas: A clinicopathological and survival analysis. The Veterinary Journal 2011, 187:65-71.
83. Simeonov R., Simeonova G. Nuclear cytomorphometry in feline mammary gland epithelial tumours. The Veterinary Journal 2009, 179:296-300.
84. Skorupski K.A., Overley B., Shofer F.S., Goldschmidt M.H., Miller C.A., Sorenmo K.U. Clinical characteristics of mammary carcinoma in male cats. Journal of Veterinary Internal Medicine/American College of Veterinary Internal Medicine 2005, 19:52-55.
85. Soslow R.A., Dannenberg A.J., Rush D., Woerner B.M., Khan K.N., Masferrer J., Koki A.T. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer 2000, 89:2637-2645.
86. Sutherland R.L., Musgrove E.A. Cyclins and breast cancer. Journal of Mammary Gland Biology and Neoplasia 2004, 9:95-104.
87. Tadrous P.J. Breast. Diagnostic Criteria Handbook in Histopathology: A Surgical Pathology Vade Mecum 2007, 258-266. John Wiley, Chichester, UK.
88. Takeuchi K., Ito F. Receptor tyrosine kinases and targeted cancer therapeutics. Biological & Pharmaceutical Bulletin 2011, 34:1774-1780.
89. Tanabe S., Nakadai T., Furuoka H., Oomachi T., Kobayashi Y., Omata Y., Koyama T., Hondo E., Uzuka Y., Sarashina T., Ducusin R.J., Shida T., Dorf M.E. Expression of mRNA of chemokine receptor CXCR4 in feline mammary adenocarcinoma. Veterinary Record 2002, 151:729-733.
90. Vail D.M., MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Investigation 2000, 18:781-792.
91. Watson C.J., Miller W.R. Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. British Journal of Cancer 1995, 71:840-844.
92. Webster J.D., Dennis M.M., Dervisis N., Heller J., Bacon N.J., Bergman P.J., Bienzle D., Cassali G., Castagnaro M., Cullen J., Esplin D.G., Pena L., Goldschmidt M.H., Hahn K.A., Henry C.J., Hellmen E., Kamstock D., Kirpensteijn J., Kitchell B.E., Amorim R.L., Lenz S.D., Lipscomb T.P., McEntee M., McGill L.D., McKnight C.A., McManus P.M., Moore A.S., Moore P.F., Moroff S.D., Nakayama H., Northrup N.C., Sarli G., Scase T., Sorenmo K., Schulman F.Y., Shoieb A.M., Smedley R.C., Spangler W.L., Teske E., Thamm D.H., Valli V.E., Vernau W., von Euler H., Withrow S.J., Weisbrode S.E., Yager J., Kiupel M. Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology. Veterinary Pathology 2011, 48:7-18.
93. Weijer K., Hart A.A. Prognostic factors in feline mammary carcinoma. Journal of the National Cancer Institute 1983, 70:709-716.
94. Winston J., Craft D.M., Scase T.J., Bergman P.J. Immunohistochemical detection of HER-2/neu expression in spontaneous feline mammary tumours. Veterinary and Comparative Oncology 2005, 3:8-15.
95. Yerushalmi R., Woods R., Ravdin P.M., Hayes M.M., Gelmon K.A. Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncology 2010, 11:174-183.
96. Zappulli V., De Zan G., Cardazzo B., Bargelloni L., Castagnaro M. Feline mammary tumours in comparative oncology. Journal of Dairy Research 2005, 72:98-106. (Spec. No).